Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jul;66(1):107-12.
doi: 10.1016/j.pep.2009.02.009. Epub 2009 Feb 20.

Expression and purification of amyloid-beta peptides from Escherichia coli

Affiliations

Expression and purification of amyloid-beta peptides from Escherichia coli

Kanchan Garai et al. Protein Expr Purif. 2009 Jul.

Abstract

Soluble oligomers and fibrillar deposits of amyloid beta (Abeta) are key agents of Alzheimer's disease pathogenesis. However, the mechanism of amyloid aggregation and its interaction with live cells still remain unclear requiring the preparation of large amounts of pure and different Abeta peptides. Here we describe an Escherichia coli expression system using a fusion protein to obtain either Abeta(1-40) or Abeta(1-42) by essentially the same procedure. The fusion protein uses a His-tagged intestinal fatty acid binding protein (IFABP) followed by a six-glycine linker and a Factor Xa cleavage site before the Abeta. The advantages of this system are that the fusion protein can be expressed in large amounts, that the fusion partner, IFABP, has been well characterized in terms of folding, that Abeta or mutated Abeta peptides can be obtained without any extra residues attached to the N-terminus and that the system can be used to incorporate fluorine-labeled amino acids. The incorporation of fluorine-labeled amino acids using auxotrophic strains is a useful NMR probe of side chain behavior. We obtain final yields of 4 and 3mg/L of culture for Abeta(1-40) and Abeta(1-42), respectively.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Construct of the pQE-80L-IFABP-Aβ expression vector.
Figure 2
Figure 2
Diagrammatic scheme of the purification protocol.
Figure 3
Figure 3
SDS PAGE gels of cell extracts. a) IFABP-A 1–40. Lane 1, cell extract supernatant. Lane 2, pellet of the cell extract of dissolved in 8 M urea. Lane 3, molecular weight markers. b) IFABP-A 1–42. Lane 1, cell extract supernatant. Lane 2, pellet of cell extract dissolved in 8 M urea. Lane 3, molecular weight markers. The fusion protein band is circled in Figure 3a and 3b.
Figure 4
Figure 4
SDS Page gels showing Factor Xa cleavage of the fusion proteins. a) IFABP-A 1–40. Lane 1, Ni-NTA column purified fusion protein. Lane 2, after purification with size exclusion chromatography and prior to cleavage with Factor Xa, Lane 3, after cleavage with Factor Xa. Lane 4, molecular weight markers. b) IFABP-A 1–42. Lane 1, Ni-NTA column purified fusion protein. Lane 2, after purification with size exclusion chromatography and prior to cleavage with Factor Xa, Lane 3, after cleavage with Factor Xa. Lane 4, molecular weight markers.
Figure 5
Figure 5
SDS-PAGE gel of purified A 1–40 and A 1–42. Purified A 1–40 (Lane 1), and A 1–42 (Lane 2). Markers shown in Lane 3.
Figure 6
Figure 6
Mass spectrometry of purified A 1–40 and A 1–42. a) Electrospray mass spectrometry of A 1–40. The theoretical mass is 4329 daltons. The peaks at 4351, 4373 and 4393 daltons correspond to one, two and three sodium atoms bound to A 1–40. b) Mass spectrometry of A 1–42. The theoretical mass is 4514 daltons. The peak at 4536 daltons corresponds to presence of one sodium atom bound to A 1–42

References

    1. Selkoe DJ. The molecular pathology of Alzheimer’s disease. Neuron. 1991;6:487–498. - PubMed
    1. Selkoe DJ. Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev. 2001;81:741–766. - PubMed
    1. Teplow DB. Structural and kinetic features of amyloid beta-protein fibrillogenesis. Amyloid. 1998;5:121–142. - PubMed
    1. Lorenzo A, Yankner BA. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo Red. Proc Natl Acad Sci U S A. 1994;91:12243–12247. - PMC - PubMed
    1. Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, Benedek GB, Selkoe DJ, Teplow DB. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem. 1999;274:25945–25952. - PubMed

Publication types

MeSH terms

LinkOut - more resources